Snowball logo
logo
AMGX_logo

AnGes Inc

AMGXF OTCGREY
$0.3602$0.00  (0%)
Estimate
EPS
-0.79
Beta
0.636
About the company
Ticker
AMGXF
ISIN
Country
Japan
Sector (GICS)
Healthcare
AnGes, Inc. engages in the research and development of gene-based medicines. It develops HGF gene therapy product for the treatment of chronic arterial occlusive disease; NF-KB decoy oligonucleotide for chronic discogenic lumbar back pain; and DNA vaccines for the treatment of hypertension, as well as tie2 agonists for COVID-19/ARDS and drugs for chronic hepatitis B. AnGes, Inc. was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. The company was incorporated in 1999 and is headquartered in Ibaraki, Japan.

Frequently asked questions

What sector does AnGes Inc (AMGXF) operate in?

AnGes Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is AnGes Inc (AMGXF) current stock price?

As of the latest data, AnGes Inc stock price is $0.36, with a previous close of $0.36.

What is AnGes Inc (AMGXF) current market capitalization?

AnGes Inc market cap is approximately 142.50 million.

What is AnGes Inc (AMGXF) Earnings Per Share (EPS)?

The trailing EPS is -$0.79.

Does AnGes Inc (AMGXF) pay dividends?

No. AnGes Inc does not pay a dividend.

When is AnGes Inc (AMGXF) next earnings report?

AnGes Inc is expected to release its next earnings report on June 30, 2026.

What is AnGes Inc (AMGXF) beta (volatility) score?

AnGes Inc has a beta of 0.636, indicating lower volatility than the overall market.